Reardon, David A. http://orcid.org/0000-0001-6674-0157
Cahill, Daniel P.
Article History
First Online: 17 July 2023
Competing interests
: D.A.R. has received financial compensation for advisory roles at Agios, AnHeart Therapeutics, Avita Biomedical, Blue Rock Therapeutics, Bristol–Myers Squibb, Boston Biomedical, CureVac AG, Del Mar Pharma, DNAtrix, Hoffman-LaRoche, Imvax, Janssen, Kiyatec, Medicenna Therapeutics, Neuvogen, Novartis, Novocure, Pyramid, Sumitomo Dainippon Pharma, Vivacitas Oncology and Y-mabs Therapeutics. D.P.C. has had consultant roles for Advise Connect Inspire, Boston Pharmaceuticals, Boston Scientific, German Accelerator, GlaxoSmithKline, Iconovir, Lilly, the Massachusetts Institute of Technology and Pyramid Biosciences.